Human genetic studies indicate that NOD2 mutations modulate susceptibility to fungal infections such as invasive aspergillosis by altering cytokine responses and phagocytosis, with some loss-of-function variants paradoxically conferring resistance, underscoring its complex role in antifungal immunity (Gresnigt et al, 2018a). This evidence concerns the gene NOD2 and fungal infectious disease.